Production of serotonin syndrome by 8-OH DPAT in Cryptotis parva

被引:13
作者
Darmani, NA [1 ]
Zhao, W [1 ]
机构
[1] Kirksville Coll Osteopath Med, Dept Pharmacol, Kirksville, MO 63501 USA
关键词
least shrew; Cryptotis parva; serotonin syndrome; 8-OH DPAT; S(-)UH 301; NAN-190; propranolol; SR; 46349B;
D O I
10.1016/S0031-9384(98)00174-7
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
We have previously shown that the 5-HT2A/C agonist, DOI; potently and in a dose-dependent manner produces the head-twitch response in the least shrew (Cryptotis pawn) via the activation of serotonergic 5-HT2A receptors. The purpose of the present study was to determine whether activation of 5-HT1A receptors by its selective agonist, 8-OH DPAT, can induce the serotonin syndrome (SS) in this species. In the rat the symptoms of SS include: forepaw spraying, hindleg abduction, forepaw treading, flat body posture, tremor, and straub tail. Intraperitoneal (i.p.) administration of 8-OH DPAT produced four classic symptoms (forepaw splaying, hindleg abduction, forepaw treading, and straub tail) of SS in the least shrew in a dose-dependent manner in the 30-min observation period. The mean total cumulative score for all components of SS also significantly increased in intensity in a dose-dependent fashion. Administration of selective 5-HT1A antagonists [S(-)UH 301 or NAN-190] potently blocked the 8-OH DPAT-induced mean total SS score in a dose-dependent manner. Moreover, these antagonists had similar potencies as indicated by their identical ID50 values (0.5 and 0.52 mg/kg respectively). However, unexpectedly and unlike the published findings in the rat, the nonselective 5-HT1A antagonist with b-blocking activity, propranolol, failed to attenuate the induced response in this species. As was expected, the selective 5-HT2A/C antagonist, SR 46349B, did not affect the intensity 8-OH DPAT-induced symptoms. Overall, these data suggest that the SS produced by 8-OH DPAT in the least shrew is mediated via the activation of serotonergic 5-HT1A receptors. In addition, propranolol is not a useful 5-HT1A antagonist in this species. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:327 / 331
页数:5
相关论文
共 23 条
[1]   8-HYDROXY-2-(DI-NORMAL-PROPYLAMINO)TETRALIN, A NEW CENTRALLY ACTING 5-HYDROXYTRYPTAMINE RECEPTOR AGONIST [J].
ARVIDSSON, LE ;
HACKSELL, U ;
NILSSON, JLG ;
HJORTH, S ;
CARLSSON, A ;
LINDBERG, P ;
SANCHEZ, D ;
WIKSTROM, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1981, 24 (08) :921-923
[2]  
BJORK L, 1991, J PHARMACOL EXP THER, V258, P58
[3]   DO FUNCTIONAL-RELATIONSHIPS EXIST BETWEEN 5-HT1A AND 5-HT2 RECEPTORS [J].
DARMANI, NA ;
MARTIN, BR ;
PANDEY, U ;
GLENNON, RA .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 36 (04) :901-906
[4]   THE HEAD-TWITCH RESPONSE IN THE LEAST SHREW (CRYPTOTIS-PARVA) IS A 5-HT2-MEDIATED AND NOT A 5-HT1C-MEDIATED PHENOMENON [J].
DARMANI, NA ;
MOCK, OB ;
TOWNS, LC ;
GERDES, GF .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1994, 48 (02) :383-396
[5]  
DARMANI NA, IN PRESS SEROTONIN 5
[6]   5-HT1A AND 5-HT2 RECEPTORS MEDIATE DISCRETE BEHAVIORS IN THE MONGOLIAN GERBIL [J].
EISON, AS ;
WRIGHT, RN .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1992, 43 (01) :131-137
[7]  
FORNAL CA, 1994, J PHARMACOL EXP THER, V270, P1359
[8]   A PHARMACOLOGICAL PROFILE OF THE SELECTIVE SILENT 5-HT1A RECEPTOR ANTAGONIST, WAY-100635 [J].
FORSTER, EA ;
CLIFFE, IA ;
BILL, DJ ;
DOVER, GM ;
JONES, D ;
REILLY, Y ;
FLETCHER, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 281 (01) :81-88
[9]  
GLENNON RA, 1988, SEROTONIN, P353
[10]   THE PHARMACOLOGY OF THE BEHAVIORAL AND HYPOTHERMIC RESPONSES OF RATS TO 8-HYDROXY-2-(DI-NORMAL-PROPYLAMINO)TETRALIN (8-OH-DPAT) [J].
GOODWIN, GM ;
DESOUZA, RJ ;
GREEN, AR ;
HEAL, DJ .
PSYCHOPHARMACOLOGY, 1987, 91 (04) :506-511